Hopp til innhold
NHI.no
Annonse

Misofoni: Forekomst

Innhold i artikkelen

Det er usikkert nøyaktig hvor mange som har misofoni, men internasjonale studier anslår at det kan gjelde mellom 4 og 20 prosent av befolkningen. Symptomene starter vanligvis i barndommen eller i tidlige ungdomsår.

Annonse

Dette dokumentet er basert på det profesjonelle dokumentet Misofoni . Referanselisten for dette dokumentet vises nedenfor

  1. Swedo SE, Baguley DM, Denys D, et al. Consensus Definition of Misophonia: A Delphi Study. Front Neurosci. 2022; 16: 841816. PMID:35368272. PubMed
  2. Henry JA, Theodoroff SM, Edmonds C, et al. Sound Tolerance Conditions (Hyperacusis, Misophonia, Noise Sensitivity, and Phonophobia): Definitions and Clinical Management. Am J Audiol. 2022;31(3):513-527. PMID:35858241. PubMed
  3. Suhnan AP, Finch PM, Drummond PD. Hyperacusis in chronic pain: neural interactions between the auditory and nociceptive systems. Int J Audiol. 2017 Nov;56(11):801-809. PMID: 28685627 PubMed
  4. Williams ZJ, He JL, Cascio CJ, Woynaroski TG. A review of decreased sound tolerance in autism: Definitions, phenomenology, and potential mechanisms. Neurosci Biobehav Rev. 2021 Feb;121:1-17. PMID: 33285160 PubMed
  5. Ferrer-Torres A, Giménez-Llort L. Misophonia: A Systematic Review of Current and Future Trends in This Emerging Clinical Field. Int J Environ Res Public Health. 2022;19(11):6790. PMID:35682372 PubMed
  6. Vitoratou S, Hayes C, Uglik-Marucha N, et al. Misophonia in the UK: Prevalence and norms from the S-Five in a UK representative sample. PLoS One 2023; 18: e0282777. pmid:36947525 PubMed
  7. Dixon LJ, Schadegg MJ, Clark HL, et al. Prevalence, phenomenology, and impact of misophonia in a nationally representative sample of U.S. adults. J Psychopathol Clin Sci. 2024 Jul;133(5):403-412. PMID: 38780601 PubMed
  8. Brout JJ, Edelstein M, Erfanian M, et al. Investigating Misophonia: A Review of the Empirical Literature, Clinical Implications, and a Research Agenda. Front Neurosci. 2018 Feb 7;12:36. PMID: 29467604 PubMed
  9. Jastreboff PJ, Jastreboff MM. The neurophysiological approach to misophonia: Theory and treatment. Front Neurosci. 2023 Mar 23;17:895574. PMID: 37034168 PubMed
  10. Mattson SA, D'Souza J, Wojcik KD, et al. A systematic review of treatments for misophonia. Pers Med Psychiatry. 2023 Jul-Aug;39-40:100104. Epub 2023 May 3. PMID: 37333720 PubMed
  11. Kumar S, Tansley-Hancock O, Sedley W, Winston JS, Callaghan MF, Allen M, Cope TE, Gander PE, Bamiou DE, Griffiths TD. The Brain Basis for Misophonia. Curr Biol. 2017 Feb 20;27(4):527-533. PMID: 28162895 PubMed
  12. Kumar S, Dheerendra P, Erfanian M, Benzaquén E, Sedley W, Gander PE, Lad M, Bamiou DE, Griffiths TD. The Motor Basis for Misophonia. J Neurosci. 2021 Jun 30;41(26):5762-5770. PMID: 34021042 PubMed
  13. Cassiello-Robbins C, Anand D, McMahon K, et al. The Mediating Role of Emotion Regulation Within the Relationship Between Neuroticism and Misophonia: A Preliminary Investigation. Front Psychiatry. 2020 Aug 28;11:847. PMID: 33005154 PubMed
  14. Zai G, Dembo J, Levitsky N, Richter MA. Misophonia: A Detailed Case Series and Literature Review. Prim Care Companion CNS Disord. 2022;24(5):21cr03124. PMID:36179361. PubMed
  15. Dozier TH, Lopez M, Pearson C. Proposed Diagnostic Criteria for Misophonia: A Multisensory Conditioned Aversive Reflex Disorder. Front Psychol. 2017 Nov 14;8:1975. PMID: 29184520 PubMed
  16. Jastreboff PJ, Jastreboff MM. The neurophysiological approach to misophonia: Theory and treatment. Front Neurosci. 2023 Mar 23;17:895574. PMID: 37034168 PubMed
  17. Potgieter I, MacDonald C, Partridge L, Cima R, Sheldrake J, Hoare DJ. Misophonia: A scoping review of research. J Clin Psychol. 2019;75(7):1203-1218. PMID:30859581 PubMed
  18. Potgieter I, MacDonald C, Partridge L, et al. Misophonia: A scoping review of research. J Clin Psychol. 2019 Jul;75(7):1203-1218. Epub 2019 Mar 11. PMID: 30859581 PubMed
  19. Webb J. β-Blockers for the Treatment of Misophonia and Misokinesia. Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):13-14. PMID: 35029865 PubMed
  20. Smith EEA, Guzick AG, Draper IA, et al. Perceptions of various treatment approaches for adults and children with misophonia. J Affect Disord. 2022 Nov 1;316:76-82. Epub 2022 Aug 12. PMID: 35970326 PubMed
  21. Jastreboff, P. J., & Jastreboff, M. M. Treatments for Decreased Sound Tolerance (Hyperacusis and Misophonia). Seminars in Hearing, 35(2), 105–120. 2014. https://doi.org/10.1055/s-0034-1372527
  22. Schröder AE, Vulink NC, van Loon AJ, Denys DA. Cognitive behavioral therapy is effective in misophonia: An open trial. J Affect Disord. 2017 Aug 1;217:289-294. PMID: 28441620 PubMed
  23. Jager IJ, Vulink NCC, Bergfeld IO, van Loon AJJM, Denys DAJP. Cognitive behavioral therapy for misophonia: A randomized clinical trial. Depress Anxiety. 2020 Dec 18;38(7):708–18. PMID: 33336858 PubMed
  24. Henry JA, Theodoroff SM, Edmonds C, Martinez I, Myers PJ, Zaugg TL, Goodworth MC. Sound Tolerance Conditions (Hyperacusis, Misophonia, Noise Sensitivity, and Phonophobia): Definitions and Clinical Management. Am J Audiol. 2022 Sep;31(3):513-527. PMID: 35858241 PubMed
Annonse
Annonse